
Opinion|Videos|October 18, 2024
Safety and Efficacy of RSV Vaccines in Older Adults
Author(s)Carrie Koenigsfeld, PharmD, FAPhA
Key Takeaways
- ConquerRSV, AReSVi-006, and RENOIR trials show significant efficacy in preventing RSV-related illness in older adults.
- The vaccines have demonstrated generally well-tolerated safety profiles with manageable side effects.
Carrie Koenigsfeld, PharmD, FAPhA, discusses the RSV vaccines currently available for older adults, highlighting the efficacy and safety profiles of the ConquerRSV, AReSVi-006, and RENOIR trials.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Provide an overview of the RSV vaccines currently available for older adults, highlighting the efficacy and safety profiles of the ConquerRSV, AReSVi-006, and RENOIR trials.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement